The Critical Side Effect Doctors Aren't Discussing: Out-of-Pocket Costs
In this video, I talk about why doctors should talk to patients about out-of-pocket costs when evaluating treatment options.
In this video, I talk about why doctors should talk to patients about out-of-pocket costs when evaluating treatment options.
There have been many wonderful new medications in the past decade or so, drugs that finally bring hope for many people with serious illnesses like rheumatoid arthritis, multiple sclerosis and even some advanced cancers. But these drugs often come at a high price. Here is a snapshot of drug spending in 2014, courtesy of the…
In a recent Atlantic post, James Hamblin reports on the increasing frequency with which surgeons perform hysterectomies with the assistance of robots. Here is a picture from that post: To be clear: robotic surgery doesn’t mean a robot performs the operation. Instead, the surgeon uses a laparoscope, usually, and the surgeon controls the tools at…
When I think of the federal government, “efficiency” is rarely the first thing on my mind. But when it comes to controlling healthcare costs, we need to consider the possibility that the federal government is better at this job than anyone else. Consider the fact that the United States dwarfs other countries in healthcare spending,…
In August of 2009, Sarah Palin claimed that the health legislation being crafted by Democrats at the time would create a “death panel,” in which government bureaucrats would decide whether disabled and elderly patients are “worthy of healthcare.” Despite being debunked by fact-checkers and mainstream media outlets, this myth has persisted, with almost half of…
The role of race in college and graduate school admissions remains controversial in the U.S. In fact, the Supreme Court is currently taking up a challenge to a University of Texas program that considers race in its admission decisions. Critics of race-based admissions question whether educational institutions would serve the goals of affirmative action better by…
The American Urological Association (the AUA) is outraged that the Unites State Preventative Services Task Force doesn’t support, has even “disparaged,” PSA screening. Dr. John Lynch, a member of its Board of Directors, even appealed to prostate cancer survivors to lobby against the Task Force’s recommendation, painting a dire picture of life without this controversial screening test:
read more